Mar 10, 2020 / 08:30PM GMT
Operator
Welcome to Sunesis Pharmaceuticals' Fourth Quarter and Year End 2019 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker, Mr. Willie Quinn, Chief Financial Officer and Senior Vice President, Corporate Development. Please go ahead.
William P. Quinn - Sunesis Pharmaceuticals, Inc. - Senior VP of Finance & Corporate Development and CFO
Welcome, everyone, and thank you for joining us. With me today are Dayton Misfeldt, Interim Chief Executive Officer; Judy Fox, Chief Scientific Officer, Executive Vice President, Research and Development; and Par Hyare, Senior Vice President, Commercial.
Dayton will review recent corporate events. Judy will provide more details on our pipeline, and I will provide a brief financial overview of fourth quarter 2019. We will then open the call for questions, for which we will all be available.
Before we begin, let me remind you that during today's conference call,
Q4 2019 Sunesis Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot